Aileron Obtains $10M to Further Peptide Drugs Targeting Intracellular Protein-Protein Interactions
Money will allow firm to open a research facility and expand team focused on discovery activities. Aileron Therapeutics raised $10 million through a private placement of preferred stock. The firm plans to use …
Read guide →